...
首页> 外文期刊>Journal of Molecular Biology >Structures of REV1 UBM2 Domain Complex with Ubiquitin and with a Small-Molecule that Inhibits the REV1 UBM2–Ubiquitin Interaction
【24h】

Structures of REV1 UBM2 Domain Complex with Ubiquitin and with a Small-Molecule that Inhibits the REV1 UBM2–Ubiquitin Interaction

机译:Rev1 UBM2结构域复合物与泛素和抑制Rev1 UBM2-泛素相互作用的小分子

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

REV1 is a DNA damage tolerance protein and encodes two ubiquitin-binding motifs (UBM1 and UBM2) that are essential for REV1 functions in cell survival under DNA-damaging stress. Here we report the first solution and X-ray crystal structures of REV1 UBM2 and its complex with ubiquitin, respectively. Furthermore, we have identified the first small-molecule compound, MLAF50, that directly binds to REV1 UBM2. In the heteronuclear single quantum coherence NMR experiments, peaks of UBM2 but not of UBM1 are significantly shifted by the addition of ubiquitin, which agrees to the observation that REV1 UBM2 but not UBM1 is required for DNA damage tolerance. REV1 UBM2 interacts with hydrophobic residues of ubiquitin such as L8 and L73. NMR data suggest that MLAF50 binds to the same residues of REV1 UBM2 that interact with ubiquitin, indicating that MLAF50 can compete with the REV1 UBM2–ubiquitin interaction orthosterically. Indeed, MLAF50 inhibited the interaction of REV1 UBM2 with ubiquitin and prevented chromatin localization of REV1 induced by cisplatin in U2OS cells. Our results structurally validate REV1 UBM2 as a target of a small-molecule inhibitor and demonstrate a new avenue to targeting ubiquitination-mediated protein interactions with a chemical tool.
机译:Rev1是DNA损伤耐受性蛋白质,编码两个泛素结合的基序(UBM1和UBM2),对于DNA损伤应力下的细胞存活中的Rev1功能是必不可少的。在这里,我们分别报道了Rev1 UBM2的第一种解决方案和X射线晶体结构及其与泛素的复合物。此外,我们已经鉴定了第一小分子化合物MLAF50,其直接与Rev1 UBM2结合。在异核单量子相干NMR实验中,UBM2的峰值但不具有UBM1的峰值通过添加泛素显着移位,这同意观察到DNA损伤耐受性需要UBM2但不是UBM1。 Rev1 UBM2与泛素的疏水性残基相互作用,例如L8和L73。 NMR数据表明,MLAF50与泛素相互作用的Rev1 UBM2的相同残留物,表明MLAF50可以用正常组织与Rev1 UBM2-ubiquitin相互作用竞争。实际上,MLAF50抑制了Rev1 UBM2与遍在蛋白的相互作用,并防止了通过U2OS细胞中顺铂诱导的Rev1的染色质定位。我们的结果在结构上验证了Rev1 UBM2作为小分子抑制剂的靶标,并证明了靶向鉴定泛素介导的蛋白质的蛋白质相互作用的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号